Kate Beard

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction

Rebecca A. Gladstone, Johanna M. Jefferies, Anna S. Tocheva et al. · Vaccine · 2015 · 133 citations · Full text

Immunology, Pneumococcal Serotype Replacement, Vaccine Target +17

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Tristan Clark, Kate Beard, Nathan J. Brendish et al. · The Lancet Respiratory Medicine · 2020 · 48 citations · Full text

Vaccination, Test-and-treat Strategy, Clinical Impact +7

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 34 citations · Full text

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 31 citations · Full text

Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial

Nathan J. Brendish, Kate Beard, Ahalya Malachira et al. · The Lancet Infectious Diseases · 2023 · 28 citations · Full text